康缘药业 (600557)

Jiangsu Kanion Pharmaceutical Co., Ltd.

ASH

Tags

SSE 580 IndexTraditional Chinese MedicineWeight Loss DrugsInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareMargin Trading and Securities LendingChina Securities Finance and Central Huijin Holdings

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 56615.88
  • Circulating A-Shares(W): 56615.88
  • Earnings Per Share(RMB): 0.3500
  • Net Assets Per Share(RMB): 8.3267
  • Operating Revenue(W RMB): 234268.84
  • Total Profit(W RMB): 25314.18
  • **Net Profit Attributable to Parent(W RMB) **: 19964.17
  • Net Profit Growth Rate(%): -44.10
  • Weighted Return on Equity(%): 4.3300
  • Operating Cash Flow Per Share(RMB): 0.6110
  • Undistributed Profit Per Share(RMB): 7.3267
  • Capital Reserve Per Share(RMB): ---

2. Main Business

The main business covers:

  • Traditional Chinese Medicine Preparations
  • Healthcare Products Manufacturing and Sales

3. Company Basic Information

  • Company Name: Jiangsu Kanion Pharmaceutical Co., Ltd.
  • Listing Date: 2002-09-18
  • Industry: Pharmaceutical Manufacturing
  • Address: Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City, Jiangsu Province
  • Website: https://www.kanion.com
  • Company Profile: In December 2000, approved by the Jiangsu Provincial People's Government and initiated by Hengrui Group, Shanghai United Venture Capital, Xiao Wei, and ten other shareholders, Lianyungang Kanion Pharmaceutical Co., Ltd. was transformed into Jiangsu Kanion Pharmaceutical Co., Ltd. based on the audited net assets of 51.8 million RMB as of October 31, 2000, converted at a 1:1 ratio. The company's registered capital was 51.8 million RMB.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Jiangsu Kanion Group Co., Ltd. General Legal Person 17617.35 31.12
2 Lianyungang Kangbeier Medical Device Co., Ltd. General Legal Person 3187.06 5.63
3 Central Huijin Asset Management Co., Ltd. Special Legal Person 1788.65 3.16
4 Hong Kong Securities Clearing Company Ltd. Northbound Capital 1447.80 2.56
5 Shanghai Yinye Investment Co., Ltd. - Yinye Gongyu No. 10 Private Securities Investment Fund Private Securities Investment Fund 1194.52 2.11
6 Founder Fubon Trend Navigation Hybrid Securities Investment Fund Class A Fund 190.08 0.34
7 Founder Fubon Strategy Selection Hybrid Securities Investment Fund Class A Fund 135.05 0.24
8 Founder Fubon Strategy Rotation Hybrid Securities Investment Fund Class A Fund 95.12 0.17
9 Founder Fubon Huifu One-Year Regular Open Flexible Allocation Hybrid Securities Investment Fund Class A Fund 60.10 0.11
10 Founder Fubon Tianrui Flexible Allocation Hybrid Securities Investment Fund Class A Fund 59.05 0.10

5. Concept Sectors

  • Innovative Drugs
  • Weight Loss Drugs
  • Margin Trading & Securities Lending
  • National Team Investment (China Securities Finance & Central Huijin)
  • SSE 580

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information